Cargando…

Cost-Effectiveness of Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease: A Systematic Review

Infliximab and adalimumab are monoclonal antibodies against tumor necrosis factor (anti-TNF) used to manage inflammatory bowel disease (IBD). Therapeutic Drug Monitoring (TDM) has been proven to prevent immunogenicity, to achieve better long-term clinical results and to save costs in IBD treatment....

Descripción completa

Detalles Bibliográficos
Autores principales: Marquez-Megias, Silvia, Nalda-Molina, Ricardo, Sanz-Valero, Javier, Más-Serrano, Patricio, Diaz-Gonzalez, Marcos, Candela-Boix, Maria Remedios, Ramon-Lopez, Amelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145467/
https://www.ncbi.nlm.nih.gov/pubmed/35631594
http://dx.doi.org/10.3390/pharmaceutics14051009

Ejemplares similares